ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 13300 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 13300; 2) Community: the network communities that were significantly associated with the response to NSC 13300; 3) Molecule: the relationships between components within communities and NSC 13300; 4) MDR: the compounds that were significantly associated with the NSC 13300.

NSC Compound Enrichment Correlation
NSC 176327 Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride 0.0222343516878698 -0.012650377
NSC 221266 Benzoic acid, 3,4-dichloro-, [1-[4-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]ethylidene]hydrazide, monohy 0.0222343516878698 0.22208233
NSC 3088 Chlorambucil 0.0222343516878698 0.024950695
NSC 53327 Null 0.0222343516878698 -0.063092784
NSC 623176 Null 0.0222343516878698 0.31000192
NSC 639174 Camptothecin Derivative 0.0222343516878698 -0.069453774
NSC 661820 Null 0.0222343516878698 0.20253194
NSC 672136 9-.alpha.-Hydroxyparthenolide 0.0222343516878698 0.39457389
NSC 675003 Benzofuran-3-carboxylic acid, 2,3-dihydro-7-hydroxy- 2-(3,4-dihydroxyphenyl)-5-(3-methoxy-3-oxo-1-propen-1-yl)-, methyl ester, stereoisomer 0.0222343516878698 0.074092641
NSC 681635 Camptothecin Derivative 0.0222343516878698 -0.051151643
Total:57  Current:28    [First] [Prev] [Next] [Last]